ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Journal and News Scan
This is an expert commentary on the state of the art in this field together with an audio commentary also available on this link
This article reports on the long-term (up to 15 year) survival of patients who participated in the COURAGE trial.
A nice short demonstration from Michael Mack of his cannulation technique for minimally invasive AVR with femoral vein cannulation
This is an interesting video documenting radiotracer labelld lung nodule incision of a small 10mm right upper lobe nodule that is really quite deep
The authors report on TAVI implantation through the brachiocephalic artery in patients without ideal femoral access. This approach is safe and feasible. The distance between access point and implant site is short, facilitating catheter manipulation and implantation itself.
Results of the Dutch National Paediatric HTx Programme are presented. Eighteen of 43 eligible patients underwent implantation of a ventricular assist device. The authors provide a detailed description of the outcomes.
Prediction of the implantation plane in transcatheter aortic valve implantation using a multislice computed tomography-based method is evaluated in 244 patients. The results reveal large interindividual differences
How to develop the perfect clinical guideline: Instructions by the European Association for Cardio-Thoracic Surgery (EACTS).
The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.
Using the STS Database, a mortality risk score was developed for adult patients undergoing congenital heart surgery. Procedure-specific outcomes differed by age category. The age-specific mortality risk score was more accurate than a score for all age categories (81% vs 78%).